Consulting Reference Information
8-3
P/N 85213-30, Manual revision: B
Table 8-1, AC solution concentration in MCS+ final collection products
AC Ratio
1:8
1:9
1:10
1:11
1:12
1:16
Donor
Hematocrit
% Anticoagulant in the plasma or platelet product
20
15.2
13.5
12.2
11.1
10.2
7.7
22
15.5
13.8
12.5
11.4
10.4
7.9
24
15.8
14.1
12.8
11.6
10.7
8.1
26
16.2
14.5
13.1
11.9
10.9
8.3
28
16.6
14.8
13.4
12.2
11.2
8.5
30
16.9
15.2
13.7
12.5
11.5
8.7
32
17.4
15.5
14.0
12.8
11.8
8.9
34
17.8
15.9
14.4
13.2
12.1
9.2
36
18.2
16.3
14.8
13.5
12.4
9.4
37
18.5
16.6
15.0
13.7
12.6
9.6
38
18.7
16.8
15.2
13.9
12.8
9.7
39
19.0
17.0
15.4
14.1
13.0
9.9
40
19.2
17.2
15.6
14.3
13.2
10.0
41
19.5
17.5
15.8
14.5
13.4
10.2
42
19.8
17.7
16.1
14.7
13.6
10.3
43
20.0
18.0
16.3
14.9
13.8
10.5
44
20.3
18.2
16.6
15.2
14.0
10.6
45
20.6
18.5
16.8
15.4
14.2
10.8
46
20.9
18.8
17.1
15.6
14.4
11.0
47
21.2
19.1
17.3
15.9
14.6
11.2
48
21.6
19.4
17.6
16.1
14.9
11.4
49
21.9
19.7
17.9
16.4
15.1
11.6
50
22.2
20.0
18.2
16.7
15.4
11.8
60
26.3
23.8
21.7
20.0
18.5
14.3
Summary of Contents for MCS+
Page 2: ...2002 2006 Haemonetics Corporation All rights reserved...
Page 10: ...x Preface P N 85213 30 Manual revision B The Haemonetics MCS LN09000 220E ED...
Page 20: ......
Page 30: ......
Page 81: ...Maintaining the MCS Equipment 5 7 P N 85213 30 Manual revision B...
Page 85: ......
Page 86: ...5 12 Maintaining the MCS Equipment P N 85213 30 Manual revision B...
Page 100: ......
